GE HealthCare Applied sciences Inc. (NASDAQ:GEHC) Q3 2024 Earnings Convention Name October 30, 2024 8:30 AM ET
Firm Individuals
Carolynne Borders – Chief Investor Relations Officer
Peter Arduini – President and Chief Govt Officer
Jay Saccaro – Vice President and Chief Monetary Officer
Convention Name Individuals
Robbie Marcus – J.P. Morgan
Ryan Zimmerman – BTIG
Joanne Wuensch – Citi
David Roman – Goldman Sachs
Larry Biegelsen – Wells Fargo
Vijay Kumar – Evercore ISI
Sezgi Ozener – HSBC
Navann Ty – BNP Paribas
Operator
Thanks for standing by, and welcome to GE HealthCare’s Third Quarter 2024 Earnings Convention Name. At the moment, all members are in a listen-only mode. After the speaker presentation, there will probably be a question-and-answer session. [Operator Instructions]
I’d now like to show the decision over to Carolynne Borders with Investor Relations. Please go forward.
Carolynne Borders
Thanks, operator. Good morning, and welcome to GE HealthCare’s third quarter 2024 earnings name. I am joined by our President and CEO, Peter Arduini; and Vice President and CFO, Jay Saccaro.
Our convention name remarks will embrace each GAAP and non-GAAP monetary outcomes. Reconciliations between GAAP and non-GAAP measures may be present in at this time’s press launch and within the presentation slides obtainable on our web site. Throughout this name, we’ll make forward-looking statements about our efficiency. These statements are primarily based on how we see issues at this time. As described in our SEC filings, precise outcomes might differ materially because of dangers and uncertainties.
With that, I will hand the decision over to Peter.
Peter Arduini
Thanks, Carolynne, and because of all these becoming a member of us at this time. Within the third quarter, we delivered 1% natural income progress, according to our expectations, with robust efficiency within the U.S. throughout all segments, and strong progress in Pharmaceutical Diagnostics. Within the quarter, we delivered optimistic worth and quantity. Natural orders progress was 1%. Excluding China, reported gross sales progress was roughly 5%, and